About this document
Clemastine Enhances Remyelination in Mice by Daniel Jiménez is a document available to read on EtoBox.
The study investigates the effects of clemastine, an FDA-approved drug, on behavioral changes and remyelination in a cuprizone mouse model of demyelination, which simulates schizophrenia-like symptoms. Results indicate that clemastine treatment significantly enhances remyelination and rescues anxiety-like behaviors in the mice, suggesting its potential as a therapeutic approach for schizophrenia. The findings highlight the importance of myelin repair in addressing the underlying neuropathological changes as
- Author
- Daniel Jiménez
- Language
- EN